Bon Natural Life Ltd (BON) stock
Close on Nov 11, 2026Market cap $9.27MP/E –Yield –
Bon Natural Life Ltd saw revenue fall 21.7% to $18.67M over fiscal 2025. Operating income fell 186.6% to -$1.62M, moving the operating margin from 7.9% to -8.7%. Free cash flow was $134.29K. At the latest close the market valued the company at $9.27M.
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Mar 31, 2026
Valuation
- Market cap
- $9.27M
- P/E ratio
- –
- Price to sales
- 0.50
- Price to book
- 0.18
- Dividend yield
- –
- Free cash flow yield
- 1.45%
Fundamentals
- Revenue
- $18.67M
- Net income
- -$1.99M
- EPS, diluted
- -$0.72
- Free cash flow
- $134.29K
Trading
- Previous close
- $1.11
- Open
- $1.15
- Day's range
- $1.11 – $1.15
- Volume
- 4,247
- Average volume (20 days)
- 9,493
- Beta (5 years)
- 0.95
- 52-week range
- $0.95 – $2.00
- RSI (14 days)
- 51.6
- Volatility (1 year)
- 44.5%
- Relative volume
- 0.48×
- WACC
- 6.4%
Market cap history
Month-end market cap since 2021, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | BON | S&P 500 | Difference | BON per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -1.7% | -2.4% | +0.7 pts | ||
| 3 months | -0.9% | -1.2% | +0.3 pts | ||
| Year to date | -28.3% | +12.3% | −40.6 pts | ||
| 1 year | -41.8% | +12.4% | −54.3 pts | ||
| 3 years | -98.9% | +78.8% | −177.7 pts | -77.8% | +21.4% |
| 5 years | -99.9% | +75.2% | −175.1 pts | -76.2% | +11.9% |
Seven years at a glance
Fiscal years 2019 to 2025, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Bon Natural Life filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
About Bon Natural Life
Medicinal Chemicals & Botanical Products
Bon Natural Life Limited is a holding company that operates primarily through its operating subsidiaries in the People's Republic of China. The company engages in the research, development, manufacture, and commercialization of specialized plant-extracted natural ingredients. Its core product portfolio comprises three principal categories: fragrance compounds, health supplements, and bioactive food ingredients. These offerings are distributed to manufacturer and wholesale customers across various downstream consumer markets.
Company profile, executives and historyBon Natural Life stock: common questions
What is Bon Natural Life's stock price?
BON closed at $1.14 on Nov 11, 2026, up 2.70% on the day. Over the past 52 weeks it traded between $0.95 and $2.00.
What is Bon Natural Life's market cap?
Bon Natural Life was worth $9.27M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is BON's P/E ratio?
Bon Natural Life lost money over fiscal 2025 (diluted EPS -$0.72), so it has no meaningful P/E ratio.
How much revenue does Bon Natural Life make?
Bon Natural Life reported revenue of $18.67M for fiscal 2025, down 21.7% from a year earlier.
Does Bon Natural Life pay a dividend?
No. Bon Natural Life has not paid a cash dividend over the last twelve months.
How has BON stock performed over the past year?
Including dividends, BON returned -41.8% over the past year, against +12.4% for the S&P 500.
How many BON shares are sold short?
0M shares were sold short at the latest FINRA report, 0.17% of the float, or 1.1 days of average trading volume.
Who are Bon Natural Life's competitors?
Companies most similar to Bon Natural Life by business, industry and size include HYEX, CYAN, MDWD, SNYRQ, BGM.
See a number that looks wrong?